Trial treatment for stomach cancer extending lives

New way of injecting drug allows double the number of patients to live beyond a year

An ongoing trial where the chemotherapy drug is injected directly into the abdominal cavity of patients with a particular type of stomach cancer has allowed more than two-thirds of them to live beyond a year.

This is double the usual number who receive conventional treatments.

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content
A version of this article appeared in the print edition of The Straits Times on May 02, 2019, with the headline 'Trial treatment for stomach cancer extending lives'. Print Edition | Subscribe